Lincocin

Lincomycin Hydrochloride, the active ingredient in Lincocin, is a lincosamide antibiotic presented as an oral tablet for systemic use. It acts against susceptible Gram‑positive and certain anaerobic bacteria and is indicated for the treatment of respiratory tract infections, skin and soft‑tissue infections, bone and joint infections, and gynecological infections in adult patients.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with robust cold‑chain logistics where required and adherence to regulatory standards.

Lincocin (lincomycin hydrochloride) is used to treat bacterial infections affecting several organ systems. - Respiratory tract infections: effective against susceptible pathogens, helping resolve pneumonia, bronchitis, and sinusitis. - Skin and soft‑tissue infections: reduces bacterial load in cellulitis, abscesses, and wound infections. - Bone and joint infections: aids in the management of osteomyelitis and septic arthritis caused by susceptible organisms. - Gynecological infections: treats bacterial vaginosis and pelvic inflammatory disease when caused by appropriate bacteria.

Like other antibiotics, lincomycin may cause adverse reactions ranging from mild to serious. Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Diarrhea: loose stools, sometimes watery. - Rash: mild skin redness or itching. - Abdominal pain: cramping or discomfort in the stomach area. - Elevated liver enzymes: transient increase in hepatic markers without symptoms. Serious or Rare Side Effects: - Clostridioides difficile colitis: severe diarrhea due to intestinal flora disruption. - Anaphylaxis: acute allergic reaction with hives, swelling, and breathing difficulty. - Hepatotoxicity: significant liver injury indicated by jaundice or elevated bilirubin.

Before prescribing lincomycin, clinicians should consider several precautionary measures to ensure safe use. - Allergy assessment: verify no known hypersensitivity to lincosamides or lincomycin. - Renal function: adjust use in patients with severe renal impairment. - Hepatic function: monitor liver enzymes in patients with pre‑existing liver disease. - Concomitant antibiotics: avoid use with macrolides that may increase risk of antagonism. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Lincomycin can interact with other medicines, altering efficacy or safety. Major Interactions (Avoid): - Erythromycin: combined use may reduce lincomycin activity and increase resistance. - Clindamycin: concurrent use may lead to antagonistic effects on bacterial protein synthesis. Moderate Interactions (Monitor Closely): - Neuromuscular blocking agents: lincomycin may potentiate their effects, requiring dose adjustment. - Warfarin: may enhance anticoagulant effect, necessitating INR monitoring. - Oral contraceptives: possible reduction in contraceptive efficacy, advise additional barrier methods.